CN113073118B - Application of Tet-off expression control system in cascade amplification of promoter activity - Google Patents

Application of Tet-off expression control system in cascade amplification of promoter activity Download PDF

Info

Publication number
CN113073118B
CN113073118B CN202010004714.5A CN202010004714A CN113073118B CN 113073118 B CN113073118 B CN 113073118B CN 202010004714 A CN202010004714 A CN 202010004714A CN 113073118 B CN113073118 B CN 113073118B
Authority
CN
China
Prior art keywords
promoter
expression
cell
cells
lentiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010004714.5A
Other languages
Chinese (zh)
Other versions
CN113073118A (en
Inventor
韦苏珍
李靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai United Laboratories Co Ltd
Original Assignee
Zhuhai United Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai United Laboratories Co Ltd filed Critical Zhuhai United Laboratories Co Ltd
Priority to CN202010004714.5A priority Critical patent/CN113073118B/en
Publication of CN113073118A publication Critical patent/CN113073118A/en
Application granted granted Critical
Publication of CN113073118B publication Critical patent/CN113073118B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/001Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/005Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
    • C12N2830/006Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB tet repressible

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses an application of a Tet-off expression regulation system in cascade amplification of promoter activity. The invention is based on the inventor's discovery that the Tet-off expression control system has the effect of cascade amplification of promoter activity, and the amplification effect of weak promoters is particularly obvious. The invention provides a method for constructing a high-efficiency expression stable cell strain by using a slow virus infection method. The method realizes short construction period, high efficiency, high expression and high stability of the cell strain, and provides reliable basis for realizing large-scale and high-level expression of the recombinant protein.

Description

Application of Tet-off expression control system in cascade amplification of promoter activity
Technical Field
The invention belongs to the technical field of biology, and particularly relates to application of a Tet-off expression regulation system in cascade amplification of promoter activity.
Background
Expression of recombinant proteins by stable mammalian cell lines is an important technology in the biopharmaceutical field for the production of protein pharmaceuticals. However, construction of stable cell lines by conventional transfection is a time-consuming and labor-consuming process. In the traditional transfection technology, exogenous genes are randomly integrated in a host cell genome, so that obvious heterogeneity appears in gene copy number and integration sites, and the obtained engineering cell strain has low protein yield and unstable expression in a long-term culture process.
Lentiviruses belong to the retrovirus family, the name being derived from this virus for a latency period of up to several years, of which the most well known is human immunodeficiency virus (HIV-1). The HIV-1 virus has a diameter of about 120nm, contains two positive strand RNAs, can effectively enter the nucleus, and has high infection efficiency on cells in the dividing stage and cells in the non-dividing stage. The slow virus can integrate the carried gene into the genome of the cell after infecting the cell, and can continuously and stably express for a long time, and simultaneously can stably inherit along with cell division, so that the slow virus becomes an effective tool for introducing exogenous genes into the cell, and is also an effective stable cell strain construction means.
The lentiviral vector is a gene therapy vector obtained by modifying the HIV-1 based, and has the characteristics of higher titer, better biological safety, stronger capability of introducing exogenous fragments and the like by removing pathogenic genes and reducing the homology of helper plasmids and vector plasmids. In the existing mature lentivirus infection method construction protein expression cell strain technology, most of lentiviruses obtained by packing HEK 293T cells through adherence culture infect HEK 293T cells or other adherence culture cells; however, the use of adherent cells to express proteins has the following drawbacks: (1) The cell density is low, the expression capacity of the exogenous gene is limited, and the protein yield is low; (2) The culture medium with serum is required for culture, and risks such as pathogen pollution and the like exist; (3) The adherence culture mode is unfavorable for large-scale culture and industrialized production. Therefore, developing a stable expression cell line constructed by using lentivirus to infect suspension cells is a requirement for the industrial production of modern recombinant proteins. In the method for constructing the high-expression cell strain by using the slow virus infection method reported by AgataOberbek et al, the cell strain capable of stably expressing the fusion protein for a long time is obtained by using the slow virus to infect the suspension-cultured CHO DG44 cells. However, the cell strain obtained by the stable cell strain construction method has low yield of only 50-250 mg/L, and can not meet the requirement of the current generation of rapidly developed biopharmaceutical productivity.
Therefore, by optimizing the expression system of the lentiviral vector, the expression level of the exogenous protein is improved, and the method becomes a research hot spot.
Disclosure of Invention
The primary purpose of the invention is to overcome the defects and shortcomings of the prior art and provide the application of a Tet-off expression control system in cascade amplification of promoter activity.
Another object of the present invention is to provide a lentiviral recombinant expression vector comprising a Tet-off expression control system.
Still another object of the present invention is to provide the use of the above lentiviral recombinant vector and a method for constructing a stable cell line with high expression by lentiviral infection.
The aim of the invention is achieved by the following technical scheme: the application of the Tet-off expression regulation system in the cascade amplification of the promoter activity is based on the discovery that the Tet-off expression regulation system has the effect of cascade amplification of the promoter activity, and the amplification effect of the Tet-off expression regulation system is particularly obvious for a weak promoter; the specific application steps are as follows: the promoter is arranged at the upstream of a transcription activator tTA2 expression element in a Tet-off expression regulation system, so that the tTA2 gene is directly driven to express, and finally the expression quantity of the target protein is improved.
The promoter is preferably a weak promoter. The weak promoter is a promoter which has relatively weak binding force with RNA polymerase compared with a constitutive viral promoter such as CMV promoter and SV40 promoter.
The weak promoter is preferably derived from a host cell' S endogenous promoter, including but not limited to the CHO endogenous promoter S100a6 promoter, CIRP promoter, PDI promoter, etc.
A lentiviral recombinant expression vector comprises a lentiviral vector skeleton containing a Tet-off expression control system and a promoter A; the promoter is arranged upstream of the transcriptional activator tTA2 expression element and is used for directly driving the tTA2 gene to express.
The Tet-off expression control system comprises a transcriptional activator tTA2, a Tet response element TRE and the like.
The promoter A is preferably a weak promoter. The weak promoter is a constitutive viral promoter with high transcription activity, such as CMV promoter, SV40 promoter, etc., and has weak binding force with RNA polymerase.
The weak promoter is preferably derived from a host cell endogenous promoter, including but not limited to CHO endogenous promoters, such as the S100a6 promoter, CIRP promoter, PDI promoter, and the like.
The CIRP promoter is preferably at least one of CIRP-P867 with a nucleotide sequence shown as SEQ ID NO.1 and CIRP-P2588 with a nucleotide sequence shown as SEQ ID NO. 2.
The PDI promoter is preferably a PDI-P598 promoter with a nucleotide sequence shown in SEQ ID NO. 3.
The S100a6 promoter is preferably an S100a6-dS18 promoter with a nucleotide sequence shown in SEQ ID NO. 4.
The lentiviral vector backbone includes, but is not limited to: pTet-IRES-EGFP, pTet-Off, pTet-On, pLUT-Off and pLUT-Off-EGFP vectors.
The lentiviral vector is applied to preparation of a high-efficiency expression stable cell strain.
The high-efficiency expression stable cell strain is preferably obtained by a lentivirus infection method.
A method for constructing a high-efficiency expression stable cell strain by using a lentivirus infection method comprises the following steps:
(1) Cloning target protein genes into multiple cloning sites in the lentiviral recombinant expression vector to obtain a lentiviral vector capable of expressing target proteins;
(2) Carrying out slow virus packaging on slow virus vectors capable of expressing target proteins to obtain virus liquid;
(3) Infecting host cells with the obtained virus liquid to obtain a high-efficiency expression stable cell bank; and further screening the cell bank to obtain the cell strain with stable efficient expression.
The target protein gene in the step (1) includes, but is not limited to, RFP, GFP, mutant line thereof, luciferase, fc fusion protein, HSA fusion protein, monoclonal antibody.
The mutant strain of GFP is preferably EGFP.
The lentiviral vector capable of expressing the target protein described in step (2) is preferably a lentiviral vector obtained in high concentration and high purity by: transferring the lentiviral vector capable of expressing the target protein into competent cells of escherichia coli, copying and amplifying in the escherichia coli, and extracting plasmids to obtain the lentiviral vector with high concentration and high purity.
The escherichia coli competent cells include but are not limited to escherichia coli TOP10 competent cells and escherichia coli DH5 alpha competent cells.
The transformation method includes but is not limited to heat shock method, electric transformation method and the like.
The steps of lentivirus packaging are preferably as follows: mixing the lentiviral vector capable of expressing the target protein with a packaging plasmid to obtain a packaging system, and transfecting the packaging system into HEK 293T cells for culture; then changing fresh culture medium, continuously culturing to obtain virus liquid; more preferably as follows:
(21) 24 hours prior to co-transfection, HEK 293T cells to be transfected were passaged at appropriate densities;
(22) On the day of transfection, observing the growth condition of HEK 293T cells under a microscope, and carrying out a transfection experiment when the cell confluency is 70-90% and the condition is good;
(23) Preparing a DNA-transfection reagent complex according to the transfection reagent specification;
(24) Dropwise adding the DNA-transfection reagent complex into HEK 293T cells to be transfected, and continuing culturing;
(25) Changing fresh culture medium; the volume ratio of fresh culture medium to the culture medium during transfection is 3:10-3:12;
(26) And (4) after transfection for 46-48 hours, taking culture solution for centrifugation, and filtering the supernatant through a 0.45 mu m filter membrane to obtain the recombinant lentivirus suspension.
The passaged medium described in step (21) includes, but is not limited to, DMEM complete medium, DMEM GluMAX medium, advanced DMEM/F12 medium, etc.
The DMEM complete medium is DMEM medium containing FBS and L-glutamine.
The concentration of the FBS in the DMEM complete medium is preferably 10% by volume.
The concentration of the L-glutamine in the DMEM complete medium is preferably 2-4 mmol/L.
In the preparation of the DNA-transfection reagent complex in the step (24), the transfection reagent includes, but is not limited to, lipofectamine2000, lipofectamine3000, turbofect and other liposome transfection reagents.
The packaging system includes but is not limited to a second generation three plasmid packaging system and a third generation four plasmid packaging system.
When the packaging system is a second generation three-plasmid system, the lentiviral vector capable of expressing the target protein is proportioned with packaging plasmids pMD2.G and psPAX2 according to the mass ratio of 5:2.5-3:2-3; preferably, mixing is performed in a mass ratio of 5:3:3, 5:3:2 or 2:1:1.
When the packaging system is a third-generation four-plasmid system, the lentiviral vector capable of expressing the target protein is proportioned with packaging plasmids pMDLg-PRRE, pRSV-Rev and pMD2.G according to the mass ratio of 5:2-3:2-3:2.5-3; mixing is preferably performed in a mass ratio of 2:1:1:1, 5:3:3:3 or 5:2:2:3.
The conditions for the centrifugation in the step (26) are preferably 800rpm to 1000rpm for 5min to 8min.
Such transfection methods include, but are not limited to, electric shock transfection, liposome transfection, PEI transfection, and the like.
The fresh medium is preferably fresh DMEM medium.
The virus solution is preferably obtained for 46-48 hours after transfection.
The host cell described in step (3) is a mammalian cell, preferably a CHO cell, including but not limited to a CHO-S cell, a CHO-DG44 cell, a CHO-K1 cell, etc.
The step of infection described in step (3) is preferably as follows: taking lentivirus suspension subjected to centrifugation and filtration treatment, and infecting cells to be infected with proper density; after the virus liquid infects cells for 4 to 6 hours, fresh CD culture medium is added for continuous culture; changing fresh culture medium 46-48 hours after virus liquid infects cells; 4-5 days after virus liquid infects cells, detecting protein expression intensity to obtain a high-efficiency stable expression cell bank; more preferably as follows:
(31) Adding the centrifuged and filtered lentivirus suspension into the prepared host cells to be infected, gently mixing, and placing into a shaker at 130rpm with 8% CO 2 Culturing at 37 ℃;
(32) 4-6 hours after virus infection, fresh CD culture medium is added, and the culture is continued;
(33) Changing fresh CD complete culture medium 46-48 hours after virus infection;
(34) Sampling and detecting the cell Viability (VCD) 4-5 days after lentivirus infection, observing the cell state by microscopic examination, detecting the protein concentration or the expression intensity of the reporter gene, and obtaining a cell pool (cell pool);
(35) The obtained high expression cell bank can be directly applied to downstream experiments such as protein expression or promoter activity research; alternatively, a monoclonal cell line having a high protein expression level may be selected by a monoclonal cell sorting technique.
The amount of lentiviral suspension described in step (31) is preferably between 0.2 and 0.6X10 per 1mL of lentiviral suspension 6 Individual CHO cells to be infected were counted.
The volume ratio of the lentiviral suspension to the CHO cells to be infected is preferably 1-2: 1, proportioning; more preferably 1:1 or 2:1 by volume.
The CHO cells to be infected include, but are not limited to, CHO-S cells, CHO-DG44 cells, CHO-K1 cells, and the like.
The medium described in step (32) is preferably a CD complete medium including, but not limited to, CD FortiCHO complete medium, CD OptiCHO complete medium, CD CHO complete medium,Expression Medium, etc.
The additional volume of fresh medium in step (32) is preferably 1.5 to 3 times the volume at the time of infection; more preferably 2.5 times.
Compared with the prior art, the invention has the following advantages and effects:
first, the present inventors have found that the Tet-off expression control system has a function of cascade amplifying the promoter activity, and is particularly remarkable in amplifying a weak promoter.
Secondly, the pLUT-off lentivirus recombinant vector modified by the invention is used as a skeleton, suspension cultured CHO cells are used as host cells, high-level expression of exogenous proteins including but not limited to monoclonal antibodies, fc fusion proteins, HSA fusion proteins and the like in the suspension cells can be realized, the protein expression quantity is more than 4 times of that of the prior reporting technology, the operation is simple, and the cell strain construction period is shorter. Compared with the traditional transfection technology, the invention has the following advantages: the lentiviral vector integrates a target protein gene into a transcription active region of a host cell genome through reverse transcriptase and integrase, so that the target protein is expressed in higher yield and has high expression stability; the construction process is simple, the steps are few, and the time consumption is short. Compared with the traditional lentivirus infection technology, the invention has the following advantages: (1) The protein expression host cell is a CHO cell in suspension culture. The suspension culture CHO cells are cultured by using a serum-free culture medium, so that adverse effects of serum on virus infection and risks of other microorganism pollution are avoided, and the suspension culture CHO cells can be applied to large-scale bioreactor culture; the suspension CHO cells have high growth speed and high cell density, can obtain the target protein with higher concentration in a shorter time, and are suitable for the later large-scale culture and the production of the target protein. (2) The virus infection efficiency is high, the positive rate of the infected suspension CHO cells is close to 100%, the virus infection efficiency can be directly applied to protein expression without resistance screening or reporter gene screening, and the construction period of cell strains is greatly shortened. (3) The yield of the cell strain stably expressed by the fusion protein constructed by the invention is more than 4 times that of the cell strain stably expressed by the fusion protein constructed by the prior art, and the long-term expression stability is good. The invention provides a novel and efficient technology for constructing a stable cell strain by infecting suspension CHO cells with replication-defective lentiviruses, realizes short cell strain construction period, high efficiency, high expression and high stability, and provides a reliable basis for realizing large-scale and high-level expression of recombinant proteins.
Drawings
FIG. 1 is a diagram of plasmid maps of recombinant lentiviral expression vectors pLUT-off-PEx-GOI and pLenti-PEx-GOI; PEx in A is a different promoter, x=1, 2,3,4, PE1 is CIRP-P2588 promoter, PE2 is CIRP-P867 promoter, PE3 is S100a6-dS18 promoter, PE4 is PDI-P598 promoter, and the same applies below; GOI is EGFP reporter gene or GLP-1-Fc fusion protein expression gene; in B, x=1, 2, goi is EGFP reporter.
FIG. 2 is a flow chart of the construction of cell lines by lentiviral infection.
FIG. 3 is a graph showing the results of comparison of expression intensities after transduction of the same recombinant expression vector into the same host cell by lentiviral infection and conventional transfection.
FIG. 4 is a graph showing the results of comparison of expression intensities of promoters containing a Tet-off expression control system and those not containing a Tet-off expression control system.
FIG. 5 is a graph showing the comparison of GFP expression intensities after 6d and 60d passages after resuscitating a pool of cells infected with pLUT-off-PEx-EGFP lentivirus.
FIG. 6 is a graph showing the results of the yield of a pLUT-off-PE3-GLP-1-Fc monoclonal cell strain cultured in a 15 mL-shake tube.
FIG. 7 is a graph showing the results of 250 mL-shake flask fermentation of a pLUT-off-PE3-GLP-1-Fc monoclonal cell strain.
FIG. 8 is a graph showing the results of comparison of yields after 6d of resuscitation and 60d of passage of a pLUT-off-PE3-GLP-1-Fc monoclonal cell line.
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but embodiments of the present invention are not limited thereto.
Example 1 construction of pLUT-off-PEx-EGFP lentiviral recombinant plasmid,
the EcoRI-EGFP-XhoI gene fragment was obtained by PCR amplification experiments using pLEGFP-C1 (ClonTech, cat#6084-1) plasmid as a template, and the PCR primers were SeqPF and SeqPR.
SeqPF:5’-ACCGGAATTCTCAGATCCGCTAGCGCTAC-3’;
SeqPR:5’-TGAGCTCGAGATCAGAGTCCGGACTTGTACAGC-3’。
EcoRI and XhoI double digestion is carried out on the EcoRI-EGFP-XhoI gene fragment and the pLUT-off plasmid (the sequence is shown as SEQ ID NO. 5), and the EcoRI-EGFP-XhoI gene fragment with the restriction enzyme cohesive end and the pLUT-off linearization vector are obtained through a glue recovery purification method. The pLUT-off linearization vector and EcoRI-EGFP-XhoI gene fragment are connected through T4DNA ligase, and the connection system and connection conditions are as follows: pLUT-off linearization vector 20ng, ecoRI-EGFP-XhoI fragment 200ng, T4 Buffer (T4 Buffer) 2. Mu. L, T4DNA ligase 1. Mu. L, ddH 2 O was made up to 20. Mu.L. Connection conditions: the reaction was carried out at 16℃overnight. And (3) transforming the ligation product into competent cells of escherichia coli TOP10, selecting a monoclonal colony for culture, performing bacterial liquid PCR (polymerase chain reaction) screening positive monoclonal, selecting a monoclonal with correct target bands for bacterial liquid culture, extracting plasmids for enzyme digestion identification, and obtaining an intermediate plasmid pLUT-off-EGFP.
Different CHO endogenous promoters (hereinafter collectively PEx, x=1, 2,3,4, PE1 is CIRP-P2588 promoter, PE2 is CIRP-P867 promoter, PE3 is S100a6-dS18 promoter, PE4 is PDI-P598 promoter) were inserted into the pvt-off-EGFP vector through SpeI and XhoI cleavage sites, respectively, wherein the PDI-P598 promoter passed through SpeI and SalI cleavage sites, to obtain a pvt-off-PEx-EGFP recombinant plasmid (plasmid map is shown in fig. 1A). Wherein the PEx gene fragment is synthesized by gold SpA.
EXAMPLE 2 second Generation packaging System lentiviral packaging and infection thereof
The process is as shown in fig. 2:
1. plasmid extraction: the plasmid extraction kit with endotoxin elimination effect is used for extracting a large amount of lentivirus recombinant vectors pLUT-off-PEx-EGFP and packaging plasmids psPAX2 (Addgene) and pMD2.G (Addgene), and simultaneously extracting lentivirus positive control plasmids pLVX-IRES-ZsGreen1 (Clontech) to obtain high-concentration high-purity endotoxin-free plasmids required by virus packaging of a lentivirus second-generation packaging system.
2. Cell culture: HEK 293T (ATCC) was resuscitated and prepared for co-transfection virus packaging experiments after 3 passages in conventional subculture methods.
3. Lentivirus packaging was performed using a second generation packaging system:
(1) HEK 293T cells were incubated at 0.3X10 at 24 hours prior to co-transfection 5 The individual cells/mL, 10mL of DMEM complete medium (4 mM L-glutamine, 10% FBS, the same applies below) was inoculated into a 25T cell culture flask and cultured in a carbon dioxide incubator; on the day of transfection, cells were observed by microscopic examination, the cell state was good, the confluence was about 70%, and the method was applicable to transfection experiments. 10mL of fresh DMEM complete medium is replaced and returned to the incubator for use.
(2) 4.6 μg of pLUT-off-PEx-EGFP, 2.7 μg of psPAX2 and 2.7 μg of pMD2.G (mass ratio about 5:3:3) were added to an appropriate amount of DMEM basal medium (without FBS) and gently mixed; followed by the addition of 20. Mu.L of transfection reagent TurboFect TM Transfection Reagent (Invitrogen, cat#R0531) was gently mixed to a final volume of 1mL; the reaction was allowed to stand at room temperature for 20min to form a DNA-transfection reagent complex.
(3) Adding the DNA-transfection reagent complex solution into HEK 293T cells to be transfected, wherein the temperature is 37 ℃ and the concentration of CO is 5% 2 Incubation in incubator.
(4) Meanwhile, a positive control group and a negative control group were set, respectively, the positive group was co-transfected with pLVX-IRES-ZsGreen1 plasmid (Clontech, cat# 632187) and the packaging vector in the above-described manner, and the negative control group was not transfected with DNA.
(5) After 28-32 hours of cultivation, the culture supernatant was gently removed, and 3mL of fresh DMEM basal medium was added to continue the cultivation.
(6) Culturing for 15-18 hr (after co-transfection for about 48 hr), collecting culture supernatant of virus packaging cell, centrifuging at 800rpm for 5min, and filtering the supernatant with 0.45 μm filter membrane to obtain slow virus solution for infection.
4. Lentiviral infection with EGFP and ZsGreen1 reporter genes:
(1) Prior to viral infection, CHO-S suspension cells (Invitrogen) were treated for density, viability and growth status. In this example, the density of CHO-S cells to be infected was 4.0X10 6 The cell/mL has the activity of 99 percent and the diameter of 11.9 mu m, and has good observation state under the mirror, and can be used for virus infection.
(2) The CHO-S suspension cells to be infected are usedExpression Medium (Mirus, cat#MIR6200) (4 mM L-glutamine, 0.3% Poloxamer 188) dilutes the cell density to 0.5X10) 6 cells/mL and dispensed into 50 mL-shake tubes, 1mL per tube and labeled.
(3) Adding the slow virus solution filtered by 0.45 μm filter membrane into CHO-S cells to be infected, and infecting 0.5X10 with 2mL virus solution/tube 6 After gently mixing individual cells (1 mL), they were returned to the shaker and continued at 130rpm,8% CO 2 Culturing at 37 ℃.
(4) 4 hours after virus infection, 5mL fresh was addedExpression Medium (4 mM L-glutamine, 0.3% Poloxamer 188) and further cultivation.
(5) 2 days after virus infection, centrifugation at 800rpm for 5min, removal of supernatant and addition of 8mL freshExpression Medium (4 mM L-glutamine in 0.3% Poloxamer 188) was resuspended and the experimental and negative control groups (NC) were supplemented with puromycin (puromycin) to a final concentration of 5. Mu.g/mL (5P) and the culture continued.
(6) 4 days after virus infection (2 days of 5P pressure culture), the viable cell density and cell viability were sampled and examined and the cell state was observed by microscopic examination, and the cell detection results are shown in Table 1 below. All cell banks were resuspended in 3mL fresh medium after centrifugation at 800 rpm. Finally, puromycin was added to a final concentration of 10. Mu.g/mL (10P) at 0.5M/mL,5mL passage, experimental and negative control groups (NC), and culture was continued.
TABLE 1 cell densities and cell viability of cell pools 4 days after lentiviral infection (2 days after 5P pressurization)
Cell bank VCD(×10 6 Individual cells/mL) Cell viability (%)
NC 1.92 85
pLVX-IRES-ZsGreenl 2.2 90
pLUT-off-PE1-EGFP 2.8 90
pLUT-off-PE2-EGFP 3.4 92
pLUT-off-PE3-EGFP 2.5 91
pLUT-off-PE4-EGFP 3.2 90
Fluorescent expression intensities of different infected groups were observed under ultraviolet lamp: the pLUT-off-PE3-GFP > pLUT-off-PE1-GFP > pLVX-IRES-ZsGreen1 is more than or equal to pLUT-off-PE2-GFP > pLUT-off-PE4-GFP > NC.
(7) 6 days after virus infection (5P pressure culture for 2 days+10P pressure culture for 2 days), the viable cell density and cell viability were sampled and examined, and the cell state was observed by microscopic examination, and the cell detection results are shown in Table 2 below.
TABLE 2 cell densities and cell viability of cell pools after 6 days post lentiviral infection (5P 2 days and 10P 2 days)
Cell bank VCD(×10 6 Individual cells/mL) Cell viability (%)
NC 0.28 20
pLVX-IRES-ZsGreen1 4.7 97
pLUT-off-PE1-EGFP 3.5 96
pLUT-off-PE2-EGFP 3.4 95
pLUT-off-PE3-EGFP 4.4 97
pLUT-off-PE4-EGFP 2.9 95
After two rounds of incremental pressure culture, the survival rate of cells of the group infected by the pLUT-off-PEx-EGFP series vector is not obviously reduced, and the growth is not obviously inhibited, which indicates that the proportion of cells containing exogenous target genes in the cell bank is close to 100%, namely, the positive rate is close to 100%.
EXAMPLE 3 third Generation packaging System lentiviral packaging and infection thereof
1. Plasmid extraction: the plasmid extraction kit with endotoxin elimination effect is used for extracting a large amount of lentivirus recombinant vectors pLUT-off-PEx-EGFP and packaging plasmids pMDLg-PRRE (Addgene), pRSV-Rev psPAX2 (Addgene) and pMD2.G (Adgene), and simultaneously extracting lentivirus positive control plasmids pLVX-IRES-ZsGreen1 to obtain high-concentration high-purity endotoxin-free plasmids required by the virus packaging of a lentivirus third-generation packaging system.
2. Cell culture: HEK 293T cells were resuscitated and passaged 3 times by conventional subculture methods and prepared for co-transfection virus packaging experiments.
3. Lentivirus packaging was performed using a third generation packaging system:
(1) HEK 293T cells were incubated at 0.3X10 at 24 hours prior to co-transfection 6 Each cell/mL, 10mL of DMEM complete medium was inoculated into a 25T cell culture flask, and cultured in a carbon dioxide incubator. On the day of transfection, cells were observed by microscopic examination, the cell state was good, the confluence was about 80%, and the method was applicable to transfection experiments. 10mL of fresh DMEM complete medium is replaced and returned to the incubator for use.
(2) Mu.g of pLUT-off-PEx-EGFP, 2. Mu.g of pMDLg-PRRE, 2. Mu.g of pRSV-Rev and 2. Mu.g of pMD2.G (mass ratio of 2:1:1:1) were added to DMEM basal medium (without FBS) and gently mixed; followed by the addition of 20. Mu.L of transfection reagent TurboFect TM Transfection Reagent, mixing gently to give a final volume of 1mL; standing at room temperature for reaction for 20min to form a DNA-transfection reagent complex;
(3) Adding the DNA-transfection reagent complex solution into HEK 293T cells to be transfected, at 37℃with 5% CO 2 Incubation in incubator.
(4) Meanwhile, a positive control group and a negative control group are respectively arranged, the positive group is co-transfected with pLVX-IRES-ZsGreen1 plasmid and packaging vector by the method, and the negative control group is not transfected with DNA.
(5) After 28-32 hours of cultivation, the supernatant was gently removed, and 3mL of fresh DMEM basal medium was added to continue the cultivation.
(6) Culturing for 15-18 hours (about 48 hours of co-transfection), taking the culture supernatant of virus packaging cells, centrifuging at 800rpm for 5 minutes, and filtering the supernatant by a 0.45 mu m filter membrane to obtain the slow-record virus suspension for infection.
4. Lentiviral infection with EGFP and ZsGreen1 reporter genes:
(1) Before virus infection, density and activity detection and growth state observation are carried out on CHO-S suspension cells to be infected. In this example, the density of CHO-S cells to be infected was 5.2X10 6 The cell/mL has the activity rate of 98 percent and the diameter of 11.2 mu m, and has good observation state under the mirror, and can be used for virus infection.
(2) Suspending CHO-S to be infectedCell useExpression Medium (4 mM L-glutamine, 0.3% Poloxamer 188) cell density was diluted to 0.5X10 6 cells/mL and dispensed into 50 mL-shake tubes, 1mL per tube and labeled.
(3) Adding the slow virus solution filtered by 0.45 μm filter membrane into CHO-S cells to be infected, 1mL virus solution/tube, i.e. 1mL virus solution is infected with 0.5X10 6 After gently mixing individual cells (1 mL), they were returned to the shaker and continued at 130rpm,8% CO 2 Culturing at 37 ℃.
(4) 4 hours after virus infection, 5mL fresh was addedExpression Medium (4 mM L-glutamine, 0.3% Poloxamer 188) and further culturing
(5) 2 days after virus infection, centrifugation at 800rpm for 5min, removal of supernatant, addition of 5mL freshExpression Medium (4 mM L-glutamine in 0.3% Poloxamer 188) and the experimental and negative control groups (NC) were resuspended with puromycin to a final concentration of 5 μg/mL (5P) and the culture was continued.
(6) 4 days after virus infection (2 days of 5P pressure culture), the viable cell density and cell viability were sampled and examined and the cell state was observed by microscopic examination, and the cell detection results are shown in Table 3 below. All cell banks were resuspended in 3mL fresh medium after centrifugation at 800 rpm. Finally, the culture was continued with a final concentration of puromycin of 10. Mu.g/mL (10P) in the experimental group and negative control group (NC) at 0.5M/mL and 5mL passages.
TABLE 3 cell densities and cell viability of cell pools 4 days after lentiviral infection (2 days after 5P pressurization)
Cell bank VCD(×10 6 Individual cells/mL) Cell viability (%)
NC 2.0 90
pLVX-IRES-ZsGreen1 5.2 96
pLUT-off-PE1-EGFP 4.6 96
pLUT-off-PE2-EGFP 4.4 95
pLUT-off-PE3-EGFP 5.5 97
pLUT-off-PE4-EGFP 3.8 96
Fluorescent expression intensities of different infected groups were observed under ultraviolet lamp: pLUT-off-PE3-GFP > pLUT-off-PE1-GFP
>pLVX-IRES-ZsGreen1≥pLUT-off-PE2-GFP>pLUT-off-PE4-GFP>>NC
Second generation packaging system to third generation packaging system fluorescence intensity comparison:
for pLVX-IRES-ZsGreen1 plasmid, the second generation > the third generation; for the pLUT-off-PEx-EGFP series vector, the third generation is > the second generation.
(7) 6 days after virus infection (5P pressure culture for 2 days+10P pressure culture for 2 days), the viable cell density and cell viability were sampled and examined, and the cell state was observed by microscopic examination, and the cell detection results are shown in Table 4 below.
TABLE 4 cell densities and cell viability of cell pools after 6 days post lentiviral infection (2 days 5P compression and 2 days 10P compression)
Cell bank VCD(×10 6 Individual cells/mL) Cell viability (%)
NC 0.56 30
pLVX-IRES-ZsGreen1 6.0 98
pLUT-off-PE1-EGFP 5.6 97
pLUT-off-PE2-EGFP 5.8 96
pLUT-off-PE3-EGFP 6.1 98
pLUT-off-PE4-EGFP 4.8 96
After two rounds of incremental pressurization, the survival rate of cells of the group infected by the pLUT-off-PEx-EGFP series vector is not obviously reduced, and the growth is not obviously inhibited, which indicates that the proportion of cells containing exogenous target genes in the cell bank is close to 100%, namely, the positive rate is close to 100%.
The results of example 2 and example 3, taken together, demonstrate that lentiviral infection efficiencies approaching 100% can be achieved regardless of whether the virus is packaged in a second generation packaging system or a third generation packaging system.
EXAMPLE 4 comparison of the expression intensity of pLUT-off-PEx-EGFP cell bank with the expression intensity of the conventional transfection method
(1) Transient transfection of CHO-S cells with pLUT-off-PEx-EGFP recombinant plasmid with FreeStyle MAX Reagent (Gibco TM Cat # 16447100), the transfection procedure was performed following the instructions of the reagents.
(2) 48 hours after transient transfection, cells were taken for GFP detection, while lentiviral cell banks obtained in examples 2 or 3 (cultured for less than 6 days after resuscitation) were taken for GFP detection. The cell density was measured to be 1X 10 6 The detection wavelength of each cell/mL is 480nm of emission wavelength and 520nm of absorption wavelength.
(3) The expression intensities of the same recombinant expression vector after transduction into the same host cell by different DNA delivery methods were compared. The results are shown in FIG. 3. The fluorescence expression intensity obtained by the slow virus infection method is 1.4-4.4 times of the fluorescence intensity of 48 hours after transient transfection, and the expression intensity of the vector with low expression intensity in the transient transfection process can be improved to more than 4 times by slow virus infection.
EXAMPLE 5 study of the effect of Tet-off promoter Cascade amplification
(1) PE1 (CIRP-P2588 promoter) and PE2 (CIRP-P867 promoter) with relatively weak promoter strength are taken and subcloned into lentiviral recombinant vector pliti-EGFP (the sequence is shown as SEQ ID NO. 6) through ClaI and EcoRI cleavage sites to be used as direct promoters to drive EGFP reporter gene expression, so that pLenti-PEx-GOI (shown as figure 1B) is obtained. Wherein the CIRP-P867 promoter and the CIRP-P2588 promoter are obtained by total gene synthesis of Kirschner company.
(2) Using the lentiviral infection method of example 2 or 3, the complete-PE 1-EGFP, complete-PE 2-EGFP, pLUT-off-PE1-EGFP, and pLUT-off-PE2-EGFP were transduced into CHO-S host cells, respectively, and expressed.
(3) GFP intensities were measured from a pool of lentivirus infected cells 4d after infection, and GFP expression intensities with and without Tet-off control systems were compared. The cell density was measured to be 1X 10 6 Individual cells/mL, detection wavelength: the emission wavelength is 480nm and the absorption wavelength is 520nm.
(4) As a result, as shown in FIG. 4, PE2 was hardly active without the effect of the cascade amplification of the Tet-off promoter, whereas the PE2 promoter became a strong promoter with the effect of the cascade amplification of the Tet-off promoter, and the activity was improved by 91 times; PE1 with stronger promoter activity is also improved by 4.5 times under the amplification effect of Tet-off.
EXAMPLE 6pLUT-off-PEx-EGFP cell bank stable passage experiment
(1) The pLUT-off-PEx-EGFP cell bank was resuscitated with CD FortiCHO complete medium for cultivation.
(2) When the cell density is more than or equal to 2 multiplied by 10 6 At 0.2X10 g/mL 6 The inoculation density of each cell/mL, the inoculation volume of 5mL and the complete medium of CD fortcho were subcultured.
(3) Culturing until 6 days, washing partial cells with PBS (pH 7.4, 0.01 mol/L), inoculating to black 96-well plate at appropriate cell density, detecting GFP fluorescence intensity with a multifunctional enzyme-labeled instrument under the conditions of emission wavelength 488nm and absorption wavelength 520nm, and recording as cell bank reporter gene expression intensity data at 6d of resuscitation. The remaining cells were at 0.2X10 6 Subculturing was continued with 5mL per cell/mL.
(4) Cells were harvested 60 days after subculture and GFP intensity was again measured according to step (3).
(5) GFP detection results show that the GFP expression intensity of the cell bank constructed by a lentiviral infection method after 60 days of subculture is 94-100% of the GFP expression intensity after 6 days of resuscitative culture, and the stability of different cell banks is not significantly different. FIG. 5 shows cell density of 0.25X10 6 And comparing the GFP expression intensities of the stable cell libraries before and after stable passage with each cell/mL, wherein the emission wavelength is 488nm, the absorption wavelength is 520nm.
EXAMPLE 7pLUT-off-PE3-GLP-1-Fc lentiviral packaging and infection thereof
1. Construction of pLUT-off-PE3-GLP-1-Fc lentiviral recombinant plasmid
The preparation of pLUT-off-PE3-GLP-1-Fc was described in example 1: GLP-1-Fc (Dulaglutide, trade name Trulicity) recombinant protein genes (the sequence is shown in SEQ ID NO.7 and delivered by pUC57-GLP-1-Fc recombinant vector) are synthesized by the company of Kirsrui, recombinant vectors pLUT-off-PE3-EGFP and pUC57-GLP-1-Fc are respectively digested by restriction enzymes EcoRI and XhoI, the pLUT-off-PE3 linearization vector and the GLP-1-Fc genes in the digested products are recovered by glue, and T4 ligase is connected with the linearization vector and the gene fragment to obtain the pLUT-off-PE3-GLP-1-Fc recombinant vector.
2. packaging and transfection of pLUT-off-PE3-GLP-1-Fc lentiviruses
1. Plasmid extraction: the plasmid extraction kit with endotoxin elimination effect is used for extracting a large amount of lentivirus recombinant protein expression vectors pLUT-off-PE3-GLP-1-Fc and packaging plasmids pMDLg-PRRE, pRSV-Rev and pMD2.G to obtain high-concentration high-purity endotoxin-free plasmids required by the virus packaging of a third-generation packaging system of lentiviruses.
2. Cell culture: HEK 293T cells were recovered and passaged 3 times by conventional subculture methods for use in cotransfection virus packaging experiments.
3. Lentivirus packaging was performed using the third generation packaging system virus packaging method, in the same manner as in example 3.
(1) HEK 293T cells were incubated at 0.3X10 at 24 hours prior to co-transfection 5 Complete culture of individual cells/mL, 10mL DMEMInoculating the culture medium into a 25T cell culture flask, and culturing in a carbon dioxide incubator; on the day of transfection, cells were observed by microscopic examination, the cell state was good, the confluence was about 80%, and the method was applicable to transfection experiments. 10mL of fresh DMEM complete medium is replaced and returned to the incubator for use.
(2) Add 4. Mu.g of pLUT-off-PE3-GLP-1-Fc, 2. Mu.g of pMDLg-PRRE, 2. Mu.g of pRSV-Rev and 2. Mu.g of pMD2.G (mass ratio 2:1:1:1) to DMEM basal medium (without FBS) and mix gently; followed by the addition of 20. Mu.L of transfection reagent TurboFect TM Transfection Reagent, mixing gently to give a final volume of 1mL; and standing at room temperature for reaction for 20min to form a DNA-transfection reagent complex.
(3) Adding the DNA-transfection reagent complex solution into HEK 293T cells to be transfected, wherein the temperature is 37 ℃ and the concentration of CO is 5% 2 Incubation in incubator.
(4) Meanwhile, a positive control group and a negative control group were set, the positive group was co-transfected with pLVX-IRES-ZsGreen1 plasmid and packaging vector in the above manner, and the negative control group was not transfected with DNA.
(5) After 28 to 32 hours of cultivation, the culture supernatant was gently removed, and 3mL of fresh DMEM medium was added to continue the cultivation.
(6) Culturing for 15-18 hr (about 48 hr after co-transfection), collecting culture supernatant of virus packaging cells, centrifuging at 800rpm for 5min, and filtering the supernatant with 0.45 μm filter membrane to obtain slow virus solution for infection.
4. Lentivirus infection CHO-S cell containing GLP-1-Fc fusion protein gene
(1) Before virus infection, density and activity detection and growth state observation are carried out on CHO-S suspension cells to be infected. In this example, the density of CHO-S cells to be infected was 5.8X10 6 The cell/mL has the activity of 99 percent and the diameter of 11.8 mu m, and has good observation state under the mirror, and can be used for virus infection.
(2) The density of CHO-S suspension cells to be infected was adjusted to 0.5X10 with CD fortifer complete medium 6 cells/mL and dispensed into 50 mL-shake tubes, 1mL per tube and labeled.
(3) Adding the slow virus solution filtered by 0.45 μm filter membrane into CHO-S cells to be infected, and treating 1mL of the virusVenom/tube, i.e. 1mL virus infection 0.5X10 6 Individual cells (1 mL) were gently mixed and returned to the shaker for further culture.
(4) 4 hours after virus infection, 5mL of fresh CD FortiCHO complete medium is added, and the culture is continued.
(5) 2 days after virus infection (about 48 hours), centrifugation at 800rpm for 5min, supernatant removal, and resuspension with 5mL fresh CD fortcho complete medium, and cultivation continued.
(6) 4 days after viral infection, at 0.3X10 6 The inoculation density of each cell/mL and the inoculation volume of 5mL are used for continuous culture for two days, and the cell bank is taken for limiting dilution.
EXAMPLE 8 limiting dilution method for sorting GLP-1-Fc monoclonal cell lines
(1) Preparation of cloning Medium containing 6mM L-Glutamine (per 100 mL): CD FortiCHO basal medium 97mL,200mM L-glutamine 3mL, prepared basal medium is preheated at 37 ℃ for standby.
(2) Cell bank sampling detects cell density, cell viability and observes growth status. Cells were finally diluted to 0.3 cells/40. Mu.L using a gradient dilution method with cloning medium, and the diluted cells were inoculated into 96-well plates, 40. Mu.L/well, i.e., 0.3 cells/well, using a row gun.
(3) Inoculated 96 well plates were placed in CO 2 Incubator at 37℃with 5% CO 2 And absolute resting culture under saturated humidity for 4 hours, the wells were observed under a microscope, wells containing only one cell were confirmed and labeled, and medium was added to 200. Mu.L. Repositioning cells to CO 2 The incubator continues stationary culture.
(4) After 13 days of static culture, the growth of the monoclonal cells was observed under a microscope, wells with obvious cell proliferation were found and marked, and 50. Mu.L/well of CD fortcho complete medium was supplemented.
(5) After 17 days of stationary culture, the culture supernatant of the single cell colony was picked up and subjected to SDS-PAGE detection. According to SDS-PAGE detection result, selecting the monoclonal with obvious target band, transferring to 15 mL-shaking tube, and making amplification culture.
(6) The 15 mL-shake tube system is normally cultured for 5 days, the cell viability and the viable cell density are sampled and detected, the growth state of the cells is observed under a mirror, and the monoclonal cell culture supernatant with good growth state is selected for ELISA detection, and the ELISA detection result is shown in figure 6.
(7) According to ELISA detection results, monoclonal cells with higher yield are selected and transferred to a 50 mL-shake tube for expansion culture.
(8) Culturing for 4d in a 50 mL-shake tube system, sampling and detecting the cell viability, viable cell density and observing the growth state of the cells under a microscope. After centrifugation at 800rpm for 5min, the culture supernatant was taken for ELISA detection.
(9) According to ELISA detection results, 12 monoclonal cells with higher yield are selected and transferred to a 125 mL-shake flask, and 30mLCD11V complete culture medium is subjected to expansion culture; simultaneously inoculating the strain into a 30mLCD fortcho complete culture medium to culture and prepare for strain preservation, and obtaining a stable cell strain for efficiently expressing GLP-1-Fc recombinant protein.
Example 9 shake flask fermentation yield assessment
(1) After 3d of cell culture from 50 mL-shake flask transfer to 125 mL-shake flask expansion, the cells were incubated at 0.5X10 6 Individual cells, 50mLCD11V complete medium was inoculated into 250 mL-shake flasks, 130rpm,8% CO 2 Culturing at 37deg.C, and inoculating the culture medium with the same day as 0d.
(2) Starting from 3d of fermentation, 2mL per day were sampled for the following parameter measurements: viable Cell Density (VCD), cell viability (availability), cell Diameter (Diameter), pH, osmolality, lactate concentration and glucose concentration, while observing the cell state under a microscope.
(3) When the cell density is higher than 2.0X10 7 At each cell/mL, the culture temperature was reduced to 33 ℃.
(4) When the glucose content in the culture medium is lower than 2g/L, adding glucose solution to 4g/L;
(5) The feed media PFF06 3%, 4%, 5% (V/V) were added to the fermentations 3d, 5d, 7d, 9d, 11d, 13d, respectively.
(6) Culture supernatants were taken at fermentation positions 9d, 11d, and 14d, respectively, and the effective concentration and purity of the target protein were measured by high performance liquid chromatography (HPSEC).
(7) At fermentation stage 14d or when the cell viability is below 80%, the fermentation experiment is ended and the fermentation supernatant is centrifuged for further purification.
(8) The shake flask fermentation yield of the monoclonal cell line in this example is shown in FIG. 7. In this example, the highest yield of shake flask fermentation of the cell line obtained by one time of lentiviral infection was 2g/L.
EXAMPLE 10 Stable passaging experiments with monoclonal cell lines
(1) 12 cell lines were picked and resuscitated with CD fortcho complete medium.
(2) When the cell density is greater than 2X 10 6 Each cell/mL was passaged with CD fortcho complete medium at 0.2M/mL,5mL system.
(3) Culturing until the 6 th day, the cell state is good and the doubling time is stable, and inoculating is used for shake flask fermentation yield evaluation as yield data of cell strains at the initial stage of recovery.
(4) Shake flask fermentation yield evaluation experiments were performed again after 60 days of subculture.
(5) The yields after 6 days after resuscitating and 60 days after passaging of the stable cell line were compared as shown in FIG. 8. In this example, the yield of the cell line after 60 days subculture was 94% -100% of the yield of the freshly recovered cell line.
The above examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present invention should be made in the equivalent manner, and the embodiments are included in the protection scope of the present invention.
Sequence listing
<110> Pinghai Federal pharmaceutical Co., ltd
<120> use of Tet-off expression control System in Cascade amplifying promoter Activity
<160> 9
<170> SIPOSequenceListing 1.0
<210> 1
<211> 813
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> CIRP-P867 promoter nucleotide sequence
<400> 1
gttgagggta ggaagtcgct gtcatctgtg tccccaacca cacacaccct cttgcgaagt 60
gaagaaattt ccagcatgcc attctggttg ggtggtccag actttggggt cctgtggcca 120
gggctaatgg agggccactg caggctagaa gtcagttgtt ttaggccata gaaccaccat 180
ttaaggtcag ctcagttgta tgacagtctt acatgtggtt ttgggatgat aaaagcagaa 240
gacatccctg tgtcgtgtcc cccccttgaa aatacctgtt ttccagacag ggtttctctg 300
tacctttgga gcttgtcctg gaactctata gcaggctggc ttcgtactca cagatccacc 360
tgcctctgcc tcccgagtgc tgggactaaa ggtgtgtgcc accaccaccc agtgtgtttg 420
ttcatttttg acatagagca tgtagcccag gctggtatca gacttgctgt gtagttgcaa 480
atggttttgg acttctgatc cttgtgcctc caatatccca aaggctagga gtgacaggat 540
tgtttggaaa cactctccca agttgttcca cagagtcctt tgtctcattg agtgactgga 600
tgaccggtgt gaccccgcac ttatggctca ggttccccag gaaggtcatg gattactttt 660
atatacaaaa gtagggaagg aaaggggcag gaagctttca gtgactgtca ccctagcact 720
aaagcttatg cagggcattt caagaccagt ctggcctata aagggaggtc atgtctcaaa 780
aactaaaaga ctgagtgtgc tatctggctt cag 813
<210> 2
<211> 821
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> CIRP-P2588 promoter nucleotide sequence
<400> 2
ggatgtggtc aggggtgaag ccccgccaga accctccagt gaggggctga gggcatggtc 60
aggagtccct tcagatggca tgcttgaagc cctgggtgta tgcagaagag cagtgctctg 120
ccagctgtaa tgtgcacctg gttgggggtg agcagaaagc aggattcaaa tggcagttaa 180
gttatggagc aggttgagat ttgcaggcaa actgagttgg gttcaggaga gacgctgcag 240
caagtctgaa ggaggagtac tgactttgtg gttaatattg tgatgaaagt gttaggactg 300
atcttatgga atgtctgaga gccttgggtc cagagaatca ttaggagtca gttgttttgg 360
gagtcagctc agtggataac ggggcttgct gctaatcctg aatttgatcc taaggatgga 420
aggagagaca ccagaaaatt gccttctggc tttcacacac gcacttcagc taataaatgt 480
aatattaaaa agaaaagaaa aaaaaaagca gtgcgttgaa gctctttgtt cgccgccgca 540
gaccaaccgc gcggagagca acgaagtggg tcagctccgc ccctgaaccg cgctgtcacc 600
gccctccggc cgctaggggg cgggagaatg cggccggggc acatcccagc caatcaaaac 660
gctcagcgcc tccgcgcggg cagggacgaa gccggggata gtcccgcccc tccactgaag 720
cgcagctgcc gaatctggcg cgtcggattg gtcagctagg cgtagtgggc ggttctgggg 780
ggcgtgcccg aatgggtggg gtatatcagg cgggactcag c 821
<210> 3
<211> 595
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> PDI-P598 promoter nucleotide sequence
<400> 3
cagtacggaa acgcggtcca gtcagaatgc aacacgaggg gcttcggggg cgcaggcgca 60
gctccaccca ggggcccggg actccgcccc ctgccacgtt cgacgaagaa ccgcgcaggg 120
tgcgcgcatc tctcggccaa tcaggagccg ccgggccggg ccgtggccag cggcggcccc 180
tccgggcgtg gggaaggcgt gggaaaagtc gccagtcaca agtccagaaa gagaaagttc 240
gcctcggcca gccaatcaga ggctggggaa cgcggcgtgt gagcgcgcgc gcgcgcgctg 300
cgggccaatc ccgggcgagg acggcagggc ctccgggtcc ttccgggctc cgcggccccg 360
cctcgagtgg gtgtccagtc ctcgcgcgga gagggtgggc ctctcagcgc ctcggccaat 420
cagacggcgg ggcggcgcgc gtgcgcgcgg cggctggcgc gcgcggcgag ggggcggtgt 480
gggcgcgtcc ccggcccagg atttataaag gcgaggtccg gacccaggcg cgctctcgtc 540
gccttggctg tcccggcggc gccaacccaa ccgccccgcc cgctgccgac gtccg 595
<210> 4
<211> 222
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> S100a6-dS18 promoter nucleotide sequence
<400> 4
cctcatgcca ctcccaatcc gggacagtcc tggcagcaga ggcgtggaaa actgaggggg 60
ttgttggggt gtgttttgct agcctcaggc gccgggtggg gctcggggcg ggccggcact 120
ccttgggcgg gcctcccgga tgctagccgc tataaggcca gccggactgc gacacagtcc 180
atcccctcga ccactccttt ggctcttcgc tgtctacctg cc 222
<210> 5
<211> 9494
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> pLUT-off plasmid sequence
<400> 5
acgcgtgtag tcttatgcaa tactcttgta gtcttgcaac atggtaacga tgagttagca 60
acatgcctta caaggagaga aaaagcaccg tgcatgccga ttggtggaag taaggtggta 120
cgatcgtgcc ttattaggaa ggcaacagac gggtctgaca tggattggac gaaccactga 180
attgccgcat tgcagagata ttgtatttaa gtgcctagct cgatacataa acgggtctct 240
ctggttagac cagatctgag cctgggagct ctctggctaa ctagggaacc cactgcttaa 300
gcctcaataa agcttgcctt gagtgcttca agtagtgtgt gcccgtctgt tgtgtgactc 360
tggtaactag agatccctca gaccctttta gtcagtgtgg aaaatctcta gcagtggcgc 420
ccgaacaggg acttgaaagc gaaagggaaa ccagagctct ctcgacgcag gactcggctt 480
gctgaagcgc gcacggcaag aggcgagggg cggcgactgg tgagtacgcc aaaaattttg 540
actagcggag gctagaagga gagagatggg tgcgagagcg tcagtattaa gcgggggaga 600
attagatcgc gatgggaaaa aattcggtta aggccagggg gaaagaaaaa atataaatta 660
aaacatatag tatgggcaag cagggagcta gaacgattcg cagttaatcc tggcctgtta 720
gaaacatcag aaggctgtag acaaatactg ggacagctac aaccatccct tcagacagga 780
tcagaagaac ttagatcatt atataataca gtagcaaccc tctattgtgt gcatcaaagg 840
atagagataa aagacaccaa ggaagcttta gacaagatag aggaagagca aaacaaaagt 900
aagaccaccg cacagcaagc ggccgctgat cttcagacct ggaggaggag atatgaggga 960
caattggaga agtgaattat ataaatataa agtagtaaaa attgaaccat taggagtagc 1020
acccaccaag gcaaagagaa gagtggtgca gagagaaaaa agagcagtgg gaataggagc 1080
tttgttcctt gggttcttgg gagcagcagg aagcactatg ggcgcagcgt caatgacgct 1140
gacggtacag gccagacaat tattgtctgg tatagtgcag cagcagaaca atttgctgag 1200
ggctattgag gcgcaacagc atctgttgca actcacagtc tggggcatca agcagctcca 1260
ggcaagaatc ctggctgtgg aaagatacct aaaggatcaa cagctcctgg ggatttgggg 1320
ttgctctgga aaactcattt gcaccactgc tgtgccttgg aatgctagtt ggagtaataa 1380
atctctggaa cagatttgga atcacacgac ctggatggag tgggacagag aaattaacaa 1440
ttacacaagc ttaatacact ccttaattga agaatcgcaa aaccagcaag aaaagaatga 1500
acaagaatta ttggaattag ataaatgggc aagtttgtgg aattggttta acataacaaa 1560
ttggctgtgg tatataaaat tattcataat gatagtagga ggcttggtag gtttaagaat 1620
agtttttgct gtactttcta tagtgaatag agttaggcag ggatattcac cattatcgtt 1680
tcagacccac ctcccaaccc cgaggggacc cgacaggccc gaaggaatag aagaagaagg 1740
tggagagaga gacagagaca gatccattcg attagtgaac ggatctcgac ggtatcggtt 1800
aacttttaaa agaaaagggg ggattggggg gtacagtgca ggggaaagaa tagtagacat 1860
aatagcaaca gacatacaaa ctaaagaatt acaaaaacaa attacaaaat tcaaaatttt 1920
atcgatgcag gtccgaggtt ctagacgagt ttactcccta tcagtgatag agaacgatgt 1980
cgagtttact ccctatcagt gatagagaac gtatgtcgag tttactccct atcagtgata 2040
gagaacgtat gtcgagttta ctccctatca gtgatagaga acgtatgtcg agtttatccc 2100
tatcagtgat agagaacgta tgtcgagttt actccctatc agtgatagag aacgtatgtc 2160
gaggtaggcg tgtacggtgg gaggcctata taagcagagc tcgtttagtg aaccgtcaga 2220
tcgcaccggt cagctagcac tgcagcgtct caagcttcag aattctatct agattctcga 2280
gacacgcgtg gcctccgcgc cgggttttgg cgcctcccgc gggcgccccc ctcctcacgg 2340
cgagcgctgc cacgtcagac gaagggcgca gcgagcgtcc tgatccttcc gcccggacgc 2400
tcaggacagc ggcccgctgc tcataagact cggccttaga accccagtat cagcagaagg 2460
acattttagg acgggacttg ggtgactcta gggcactggt tttctttcca gagagcggaa 2520
caggcgagga aaagtagtcc cttctcggcg attctgcgga gggatctccg tggggcggtg 2580
aacgccgatg attatataag gacgcgccgg gtgtggcaca gctagttccg tcgcagccgg 2640
gatttgggtc gcggttcttg tttgtggatc gctgtgatcg tcacttggtg agtagcgggc 2700
tgctgggctg gccggggctt tcgtggccgc cgggccgctc ggtgggacgg aagcgtgtgg 2760
agagaccgcc aagggctgta gtctgggtcc gcgagcaagg ttgccctgaa ctgggggttg 2820
gggggagcgc agcaaaatgg cggctgttcc cgagtcttga atggaagacg cttgtgaggc 2880
gggctgtgag gtcgttgaaa caaggtgggg ggcatggtgg gcggcaagaa cccaaggtct 2940
tgaggccttc gctaatgcgg gaaagctctt attcgggtga gatgggctgg ggcaccatct 3000
ggggaccctg acgtgaagtt tgtcactgac tggagaactc ggtttgtcgt ctgttgcggg 3060
ggcggcagtt atggcggtgc cgttgggcag tgcacccgta cctttgggag cgcgcgccct 3120
cgtcgtgtcg tgacgtcacc cgttctgttg gcttataatg cagggtgggg ccacctgccg 3180
gtaggtgtgc ggtaggcttt tctccgtcgc aggacgcagg gttcgggcct agggtaggct 3240
ctcctgaatc gacaggcgcc ggacctctgg tgaggggagg gataagtgag gcgtcagttt 3300
ctttggtcgg ttttatgtac ctatcttctt aagtagctga agctccggtt ttgaactatg 3360
cgctcggggt tggcgagtgt gttttgtgaa gttttttagg caccttttga aatgtaatca 3420
tttgggtcaa tatgtaattt tcagtgttag actagtaaat tgtccgctaa attctggccg 3480
tttttggctt ttttgttaga cgctagaaga tccataactt cgtatagtat acattatacg 3540
aagttatgcc accatgtcta gactggacaa gagcaaagtc ataaactctg ctctggaatt 3600
actcaatgaa gtcggtatcg aaggcctgac gacaaggaaa ctcgctcaaa agctgggagt 3660
tgagcagcct accctgtact ggcacgtgaa gaacaagcgg gccctgctcg atgccctggc 3720
aatcgagatg ctggacaggc atcataccca cttctgcccc ctggaaggcg agtcatggca 3780
agactttctg cggaacaacg ccaagtcatt ccgctgtgct ctcctctcac atcgcgacgg 3840
ggctaaagtg catctcggca cccgcccaac agagaaacag tacgaaaccc tggaaaatca 3900
gctcgcgttc ctgtgtcagc aaggcttctc cctggagaac gcactgtacg ctctgtccgc 3960
cgtgggccac tttacactgg gctgcgtatt ggaggatcag gagcatcaag tagcaaaaga 4020
ggaaagagag acacctacca ccgattctat gcccccactt ctgagacaag caattgagct 4080
gttcgaccat cagggagccg aacctgcctt ccttttcggc ctggaactaa tcatatgtgg 4140
cctggagaaa cagctaaagt gcgaaagcgg cgggccggcc gacgcccttg acgattttga 4200
cttagacatg ctcccagccg atgcccttga cgactttgac cttgatatgc tgcctgctga 4260
cgctcttgac gattttgacc ttgacatgct ccccgggtaa ataacttcgt atagtataca 4320
ttatacgaag ttatggatcc gcggccgcaa attccgcccc tctccctccc ccccccctaa 4380
cgttactggc cgaagccgct tggaataagg ccggtgtgcg tttgtctata tgttattttc 4440
caccatattg ccgtcttttg gcaatgtgag ggcccggaaa cctggccctg tcttcttgac 4500
gagcattcct aggggtcttt cccctctcgc caaaggaatg caaggtctgt tgaatgtcgt 4560
gaaggaagca gttcctctgg aagcttcttg aagacaaaca acgtctgtag cgaccctttg 4620
caggcagcgg aaccccccac ctggcgacag gtgcctctgc ggccaaaagc cacgtgtata 4680
agatacacct gcaaaggcgg cacaacccca gtgccacgtt gtgagttgga tagttgtgga 4740
aagagtcaaa tggctctcct caagcgtatt caacaagggg ctgaaggatg cccagaaggt 4800
accccattgt atgggatctg atctggggcc tcggtgcaca tgctttacat gtgtttagtc 4860
gaggttaaaa aaacgtctag gccccccgaa ccacggggac gtggttttcc tttgaaaaac 4920
acgataatac catggccacc gagtacaagc ccacggtgcg cctcgccacc cgcgacgacg 4980
tcccccgggc cgtacgcacc ctcgccgccg cgttcgccga ctaccccgcc acgcgccaca 5040
ccgttgaccc ggaccgccac atcgagcggg tcaccgagct gcaagaactc ttcctcacgc 5100
gcgtcgggct cgacatcggc aaggtgtggg tcgcggacga cggcgccgcg gtggcggtct 5160
ggaccacgcc ggagagcgtc gaagcggggg cggtgttcgc cgagatcggc tcgcgcatgg 5220
ccgagttgag cggttcccgg ctggccgcgc agcaacagat ggaaggcctc ctggcgccgc 5280
accggcccaa ggagcccgcg tggttcctgg ccaccgtcgg cgtctcgccc gaccaccagg 5340
gcaagggtct gggcagcgcc gtcgtgctcc ccggagtgga ggcggccgag cgcgctgggg 5400
tgcccgcctt cctggagacc tccgcgcccc gcaacctccc cttctacgag cggctcggct 5460
tcaccgtcac cgccgacgtc gaggtgcccg aaggaccgcg cacctggtgc atgacccgca 5520
agcccggtgc ctgagttcgc gtctggaacg tcgacaatca acctctggat tacaaaattt 5580
gtgaaagatt gactggtatt cttaactatg ttgctccttt tacgctatgt ggatacgctg 5640
ctttaatgcc tttgtatcat gctattgctt cccgtatggc tttcattttc tcctccttgt 5700
ataaatcctg gttgctgtct ctttatgagg agttgtggcc cgttgtcagg caacgtggcg 5760
tggtgtgcac tgtgtttgct gacgcaaccc ccactggttg gggcattgcc accacctgtc 5820
agctcctttc cgggactttc gctttccccc tccctattgc cacggcggaa ctcatcgccg 5880
cctgccttgc ccgctgctgg acaggggctc ggctgttggg cactgacaat tccgtggtgt 5940
tgtcggggaa gctgacgtcc tttccatggc tgctcgcctg tgttgccacc tggattctgc 6000
gcgggacgtc cttctgctac gtcccttcgg ccctcaatcc agcggacctt ccttcccgcg 6060
gcctgctgcc ggctctgcgg cctcttccgc gtcttcgcct tcgccctcag acgagtcgga 6120
tctccctttg ggccgcctcc ccgcctggaa ttaattcgag ctcggtacct ttaagaccaa 6180
tgacttacaa ggcagctgta gatcttagcc actttttaaa agaaaagggg ggactggaag 6240
ggctaattca ctcccaacga agacaagatc tgctttttgc ttgtactggg tctctctggt 6300
tagaccagat ctgagcctgg gagctctctg gctaactagg gaacccactg cttaagcctc 6360
aataaagctt gccttgagtg cttcaagtag tgtgtgcccg tctgttgtgt gactctggta 6420
actagagatc cctcagaccc ttttagtcag tgtggaaaat ctctagcagt agtagttcat 6480
gtcatcttat tattcagtat ttataacttg caaagaaatg aatatcagag agtgagagga 6540
acttgtttat tgcagcttat aatggttaca aataaagcaa tagcatcaca aatttcacaa 6600
ataaagcatt tttttcactg cattctagtt gtggtttgtc caaactcatc aatgtatctt 6660
atcatgtctg gctctagcta tcccgcccct aactccgccc atcccgcccc taactccgcc 6720
cagttccgcc cattctccgc cccatggctg actaattttt tttatttatg cagaggccga 6780
ggccgcctcg gcctctgagc tattccagaa gtagtgagga ggcttttttg gaggcctagg 6840
cttttgcggg cccaaattcg taatcatggt catagctgtt tcctgtgtga aattgttatc 6900
cgctcacaat tccacacaac atacgagccg gaagcataaa gtgtaaagcc tggggtgcct 6960
aatgagtgag ctaactcaca ttaattgcgt tgcgctcact gcccgctttc cagtcgggaa 7020
acctgtcgtg ccagctgcat taatgaatcg gccaacgcgc ggggagaggc ggtttgcgta 7080
ttgggcgctc ttccgcttcc tcgctcactg actcgctgcg ctcggtcgtt cggctgcggc 7140
gagcggtatc agctcactca aaggcggtaa tacggttatc cacagaatca ggggataacg 7200
caggaaagaa catgtgagca aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt 7260
tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa 7320
gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc cctggaagct 7380
ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc 7440
cttcgggaag cgtggcgctt tctcatagct cacgctgtag gtatctcagt tcggtgtagg 7500
tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct 7560
tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg ccactggcag 7620
cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca gagttcttga 7680
agtggtggcc taactacggc tacactagaa ggacagtatt tggtatctgc gctctgctga 7740
agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa accaccgctg 7800
gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag 7860
aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac tcacgttaag 7920
ggattttggt catgagatta tcaaaaagga tcttcaccta gatcctttta aattaaaaat 7980
gaagttttaa atcaatctaa agtatatatg agtaaacttg gtctgacagt taccaatgct 8040
taatcagtga ggcacctatc tcagcgatct gtctatttcg ttcatccata gttgcctgac 8100
tccccgtcgt gtagataact acgatacggg agggcttacc atctggcccc agtgctgcaa 8160
tgataccgcg agacccacgc tcaccggctc cagatttatc agcaataaac cagccagccg 8220
gaagggccga gcgcagaagt ggtcctgcaa ctttatccgc ctccatccag tctattaatt 8280
gttgccggga agctagagta agtagttcgc cagttaatag tttgcgcaac gttgttgcca 8340
ttgctacagg catcgtggtg tcacgctcgt cgtttggtat ggcttcattc agctccggtt 8400
cccaacgatc aaggcgagtt acatgatccc ccatgttgtg caaaaaagcg gttagctcct 8460
tcggtcctcc gatcgttgtc agaagtaagt tggccgcagt gttatcactc atggttatgg 8520
cagcactgca taattctctt actgtcatgc catccgtaag atgcttttct gtgactggtg 8580
agtactcaac caagtcattc tgagaatagt gtatgcggcg accgagttgc tcttgcccgg 8640
cgtcaatacg ggataatacc gcgccacata gcagaacttt aaaagtgctc atcattggaa 8700
aacgttcttc ggggcgaaaa ctctcaagga tcttaccgct gttgagatcc agttcgatgt 8760
aacccactcg tgcacccaac tgatcttcag catcttttac tttcaccagc gtttctgggt 8820
gagcaaaaac aggaaggcaa aatgccgcaa aaaagggaat aagggcgaca cggaaatgtt 8880
gaatactcat actcttcctt tttcaatatt attgaagcat ttatcagggt tattgtctca 8940
tgagcggata catatttgaa tgtatttaga aaaataaaca aataggggtt ccgcgcacat 9000
ttccccgaaa agtgccacct gacgtctaag aaaccattat tatcatgaca ttaacctata 9060
aaaataggcg tatcacgagg ccctttcgtc tcgcgcgttt cggtgatgac ggtgaaaacc 9120
tctgacacat gcagctcccg gagacggtca cagcttgtct gtaagcggat gccgggagca 9180
gacaagcccg tcagggcgcg tcagcgggtg ttggcgggtg tcggggctgg cttaactatg 9240
cggcatcaga gcagattgta ctgagagtgc accatatgcg gtgtgaaata ccgcacagat 9300
gcgtaaggag aaaataccgc atcaggcgcc attcgccatt caggctgcgc aactgttggg 9360
aagggcgatc ggtgcgggcc tcttcgctat tacgccagct ggcgaaaggg ggatgtgctg 9420
caaggcgatt aagttgggta acgccagggt tttcccagtc acgacgttgt aaaacgacgg 9480
ccagtgccaa gctg 9494
<210> 6
<211> 8107
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> plenti-EGFP lentiviral recombinant vector sequence
<400> 6
acgcgtgtag tcttatgcaa tactcttgta gtcttgcaac atggtaacga tgagttagca 60
acatgcctta caaggagaga aaaagcaccg tgcatgccga ttggtggaag taaggtggta 120
cgatcgtgcc ttattaggaa ggcaacagac gggtctgaca tggattggac gaaccactga 180
attgccgcat tgcagagata ttgtatttaa gtgcctagct cgatacataa acgggtctct 240
ctggttagac cagatctgag cctgggagct ctctggctaa ctagggaacc cactgcttaa 300
gcctcaataa agcttgcctt gagtgcttca agtagtgtgt gcccgtctgt tgtgtgactc 360
tggtaactag agatccctca gaccctttta gtcagtgtgg aaaatctcta gcagtggcgc 420
ccgaacaggg acttgaaagc gaaagggaaa ccagagctct ctcgacgcag gactcggctt 480
gctgaagcgc gcacggcaag aggcgagggg cggcgactgg tgagtacgcc aaaaattttg 540
actagcggag gctagaagga gagagatggg tgcgagagcg tcagtattaa gcgggggaga 600
attagatcgc gatgggaaaa aattcggtta aggccagggg gaaagaaaaa atataaatta 660
aaacatatag tatgggcaag cagggagcta gaacgattcg cagttaatcc tggcctgtta 720
gaaacatcag aaggctgtag acaaatactg ggacagctac aaccatccct tcagacagga 780
tcagaagaac ttagatcatt atataataca gtagcaaccc tctattgtgt gcatcaaagg 840
atagagataa aagacaccaa ggaagcttta gacaagatag aggaagagca aaacaaaagt 900
aagaccaccg cacagcaagc ggccgctgat cttcagacct ggaggaggag atatgaggga 960
caattggaga agtgaattat ataaatataa agtagtaaaa attgaaccat taggagtagc 1020
acccaccaag gcaaagagaa gagtggtgca gagagaaaaa agagcagtgg gaataggagc 1080
tttgttcctt gggttcttgg gagcagcagg aagcactatg ggcgcagcgt caatgacgct 1140
gacggtacag gccagacaat tattgtctgg tatagtgcag cagcagaaca atttgctgag 1200
ggctattgag gcgcaacagc atctgttgca actcacagtc tggggcatca agcagctcca 1260
ggcaagaatc ctggctgtgg aaagatacct aaaggatcaa cagctcctgg ggatttgggg 1320
ttgctctgga aaactcattt gcaccactgc tgtgccttgg aatgctagtt ggagtaataa 1380
atctctggaa cagatttgga atcacacgac ctggatggag tgggacagag aaattaacaa 1440
ttacacaagc ttaatacact ccttaattga agaatcgcaa aaccagcaag aaaagaatga 1500
acaagaatta ttggaattag ataaatgggc aagtttgtgg aattggttta acataacaaa 1560
ttggctgtgg tatataaaat tattcataat gatagtagga ggcttggtag gtttaagaat 1620
agtttttgct gtactttcta tagtgaatag agttaggcag ggatattcac cattatcgtt 1680
tcagacccac ctcccaaccc cgaggggacc cgacaggccc gaaggaatag aagaagaagg 1740
tggagagaga gacagagaca gatccattcg attagtgaac ggatctcgac ggtatcggtt 1800
aacttttaaa agaaaagggg ggattggggg gtacagtgca ggggaaagaa tagtagacat 1860
aatagcaaca gacatacaaa ctaaagaatt acaaaaacaa attacaaaat tcaaaatttt 1920
atcgatgcag gtccgaggtt ctagacgagt ttactcccta tcagtgatag agaacgatgt 1980
cgagtttact ccctatcagt gatagagaac gtatgtcgag tttactccct atcagtgata 2040
gagaacgtat gtcgagttta ctccctatca gtgatagaga acgtatgtcg agtttatccc 2100
tatcagtgat agagaacgta tgtcgagttt actccctatc agtgatagag aacgtatgtc 2160
gaggtaggcg tgtacggtgg gaggcctata taagcagagc tcgtttagtg aaccgtcaga 2220
tcgcaccggt cagctagcac tgcagcgtct caagcttcag aattctcaga tccgctagcg 2280
ctaccggtcg ccaccatggt gagcaagggc gaggagctgt tcaccggggt ggtgcccatc 2340
ctggtcgagc tggacggcga cgtaaacggc cacaagttca gcgtgtccgg cgagggcgag 2400
ggcgatgcca cctacggcaa gctgaccctg aagttcatct gcaccaccgg caagctgccc 2460
gtgccctggc ccccctcgtg accaccctga cctacggcgt gcagtgcttc agccgctacc 2520
ccgaccacat gaagcagcac gacttcttca agtccgccat gcccgaaggc tacgtccagg 2580
agcgcaccat cttcttcaag gacgacggca actacaagac ccgcgccgag gtgaagttcg 2640
agggcgacac cctggtgaac cgcatcgagc tgaagggcat cgacttcaag gaggacggca 2700
acatcctggg gcacaagctg gagtacaact acaacagcca caacgtctat atcatggccg 2760
acaagcagaa gaacggcatc aaggtgaact tcaagatccg ccacaacatc gaggacggca 2820
gcgtgcagct cgccgaccac taccagcaga acacccccat cggcgacggc cccgtgctgc 2880
tgcccgacaa ccactacctg agcacccagt ccgccctgag caaagacccc aacgagaagc 2940
gcgatcacat ggtcctgctg gagttcgtga ccgccgccgg gatcactctc ggcatggacg 3000
agctgtacaa gtccggactc tgatctcgag ggggttgggg ttgcgccttt tccaaggcag 3060
ccctgggttt gcgcagggac gcggctgctc tgggcgtggt tccgggaaac gcagcggcgc 3120
cgaccctggg tctcgcacat tcttcacgtc cgttcgcagc gtcacccgga tcttcgccgc 3180
tacccttgtg ggccccccgg cgacgcttcc tgctccgccc ctaagtcggg aaggttcctt 3240
gcggttcgcg gcgtgccgga cgtgacaaac ggaagccgca cgtctcacta gtaccctcgc 3300
agacggacag cgccagggag caatggcagc gcgccgaccg cgatgggctg tggccaatag 3360
cggctgctca gcagggcgcg ccgagagcag cggccgggaa ggggcggtgc gggaggcggg 3420
gtgtggggcg gtagtgtggg ccctgttcct gcccgcgcgg tgttccgcat tctgcaagcc 3480
tccggagcgc acgtcggcag tcggctccct cgttgaccga atcaccgacc tctctcccca 3540
gggggatcca ccggagctta ccatgaccga gtacaagccc acggtgcgcc tcgccacccg 3600
cgacgacgtc cccagggccg tacgcaccct cgccgccgcg ttcgccgact accccgccac 3660
gcgccacacc gtcgatccgg accgccacat cgagcgggtc accgagctgc aagaactctt 3720
cctcacgcgc gtcgggctcg acatcggcaa ggtgtgggtc gcggacgacg gcgccgcggt 3780
ggcggtctgg accacgccgg agagcgtcga agcgggggcg gtgttcgccg agatcggccc 3840
gcgcatggcc gagttgagcg gttcccggct ggccgcgcag caacagatgg aaggcctcct 3900
ggcgccgcac cggcccaagg agcccgcgtg gttcctggcc accgtcggcg tctcgcccga 3960
ccaccagggc aagggtctgg gcagcgccgt cgtgctcccc ggagtggagg cggccgagcg 4020
cgccggggtg cccgccttcc tggagacctc cgcgccccgc aacctcccct tctacgagcg 4080
gctcggcttc accgtcaccg ccgacgtcga ggtgcccgaa ggaccgcgca cctggtgcat 4140
gacccgcaag cccggtgcct gagtcgacaa tcaacctctg gattacaaaa tttgtgaaag 4200
attgactggt attcttaact atgttgctcc ttttacgcta tgtggatacg ctgctttaat 4260
gcctttgtat catgctattg cttcccgtat ggctttcatt ttctcctcct tgtataaatc 4320
ctggttgctg tctctttatg aggagttgtg gcccgttgtc aggcaacgtg gcgtggtgtg 4380
cactgtgttt gctgacgcaa cccccactgg ttggggcatt gccaccacct gtcagctcct 4440
ttccgggact ttcgctttcc ccctccctat tgccacggcg gaactcatcg ccgcctgcct 4500
tgcccgctgc tggacagggg ctcggctgtt gggcactgac aattccgtgg tgttgtcggg 4560
gaagctgacg tcctttccat ggctgctcgc ctgtgttgcc acctggattc tgcgcgggac 4620
gtccttctgc tacgtccctt cggccctcaa tccagcggac cttccttccc gcggcctgct 4680
gccggctctg cggcctcttc cgcgtcttcg ccttcgccct cagacgagtc ggatctccct 4740
ttgggccgcc tccccgcctg gaattaattc gagctcggta cctttaagac caatgactta 4800
caaggcagct gtagatctta gccacttttt aaaagaaaag gggggactgg aagggctaat 4860
tcactcccaa cgaagacaag atctgctttt tgcttgtact gggtctctct ggttagacca 4920
gatctgagcc tgggagctct ctggctaact agggaaccca ctgcttaagc ctcaataaag 4980
cttgccttga gtgcttcaag tagtgtgtgc ccgtctgttg tgtgactctg gtaactagag 5040
atccctcaga cccttttagt cagtgtggaa aatctctagc agtagtagtt catgtcatct 5100
tattattcag tatttataac ttgcaaagaa atgaatatca gagagtgaga ggaacttgtt 5160
tattgcagct tataatggtt acaaataaag caatagcatc acaaatttca caaataaagc 5220
atttttttca ctgcattcta gttgtggttt gtccaaactc atcaatgtat cttatcatgt 5280
ctggctctag ctatcccgcc cctaactccg cccatcccgc ccctaactcc gcccagttcc 5340
gcccattctc cgccccatgg ctgactaatt ttttttattt atgcagaggc cgaggccgcc 5400
tcggcctctg agctattcca gaagtagtga ggaggctttt ttggaggcct aggcttttgc 5460
gggcccaaat tcgtaatcat ggtcatagct gtttcctgtg tgaaattgtt atccgctcac 5520
aattccacac aacatacgag ccggaagcat aaagtgtaaa gcctggggtg cctaatgagt 5580
gagctaactc acattaattg cgttgcgctc actgcccgct ttccagtcgg gaaacctgtc 5640
gtgccagctg cattaatgaa tcggccaacg cgcggggaga ggcggtttgc gtattgggcg 5700
ctcttccgct tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt 5760
atcagctcac tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa 5820
gaacatgtga gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc 5880
gtttttccat aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag 5940
gtggcgaaac ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt 6000
gcgctctcct gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg 6060
aagcgtggcg ctttctcata gctcacgctg taggtatctc agttcggtgt aggtcgttcg 6120
ctccaagctg ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg 6180
taactatcgt cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac 6240
tggtaacagg attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg 6300
gcctaactac ggctacacta gaaggacagt atttggtatc tgcgctctgc tgaagccagt 6360
taccttcgga aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg 6420
tggttttttt gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc 6480
tttgatcttt tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt 6540
ggtcatgaga ttatcaaaaa ggatcttcac ctagatcctt ttaaattaaa aatgaagttt 6600
taaatcaatc taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag 6660
tgaggcacct atctcagcga tctgtctatt tcgttcatcc atagttgcct gactccccgt 6720
cgtgtagata actacgatac gggagggctt accatctggc cccagtgctg caatgatacc 6780
gcgagaccca cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc 6840
cgagcgcaga agtggtcctg caactttatc cgcctccatc cagtctatta attgttgccg 6900
ggaagctaga gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctac 6960
aggcatcgtg gtgtcacgct cgtcgtttgg tatggcttca ttcagctccg gttcccaacg 7020
atcaaggcga gttacatgat cccccatgtt gtgcaaaaaa gcggttagct ccttcggtcc 7080
tccgatcgtt gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact 7140
gcataattct cttactgtca tgccatccgt aagatgcttt tctgtgactg gtgagtactc 7200
aaccaagtca ttctgagaat agtgtatgcg gcgaccgagt tgctcttgcc cggcgtcaat 7260
acgggataat accgcgccac atagcagaac tttaaaagtg ctcatcattg gaaaacgttc 7320
ttcggggcga aaactctcaa ggatcttacc gctgttgaga tccagttcga tgtaacccac 7380
tcgtgcaccc aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa 7440
aacaggaagg caaaatgccg caaaaaaggg aataagggcg acacggaaat gttgaatact 7500
catactcttc ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg 7560
atacatattt gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg 7620
aaaagtgcca cctgacgtct aagaaaccat tattatcatg acattaacct ataaaaatag 7680
gcgtatcacg aggccctttc gtctcgcgcg tttcggtgat gacggtgaaa acctctgaca 7740
catgcagctc ccggagacgg tcacagcttg tctgtaagcg gatgccggga gcagacaagc 7800
ccgtcagggc gcgtcagcgg gtgttggcgg gtgtcggggc tggcttaact atgcggcatc 7860
agagcagatt gtactgagag tgcaccatat gcggtgtgaa ataccgcaca gatgcgtaag 7920
gagaaaatac cgcatcaggc gccattcgcc attcaggctg cgcaactgtt gggaagggcg 7980
atcggtgcgg gcctcttcgc tattacgcca gctggcgaaa gggggatgtg ctgcaaggcg 8040
attaagttgg gtaacgccag ggttttccca gtcacgacgt tgtaaaacga cggccagtgc 8100
caagctg 8107
<210> 7
<211> 1083
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> GLP-1-Fc recombinant protein Gene sequence
<400> 7
gaattcgctg actagcgttt aaacttaagc ttagcgcaga ggcttggggc agccgagcgg 60
cagccaggcc ccggcccggg cctcggttcc agaagggaga ggagcccgcc aaggcgcgca 120
agagagcggg ctgcctcgca gtccgagccg gagagggagc gcgagccgcg ccggccccgg 180
acggcctccg aaaccatggg cgtgaaggtc ctgttcgccc tgatttgcat cgccgtcgca 240
gaggcacacg gcgagggcac cttcacctcc gacgtgtcct cctatctcga agagcaggcc 300
gccaaggaat tcatcgcctg gctggtgaag ggcggcggcg gtggtggtgg ctccggaggc 360
ggcggctctg gtggcggtgg cagcgctgag tccaaatatg gtcccccatg cccaccctgc 420
ccagcacctg aggccgccgg gggaccatca gtcttcctgt tccccccaaa acccaaggac 480
actctcatga tctcccggac ccctgaggtc acgtgcgtgg tggtggacgt gagccaggaa 540
gaccccgagg tccagttcaa ctggtacgtg gatggcgtgg aggtgcataa tgccaagaca 600
aagccgcggg aggagcagtt caacagcacg taccgtgtgg tcagcgtcct caccgtcctg 660
caccaggact ggctgaacgg caaggagtac aagtgcaagg tctccaacaa aggcctcccg 720
tcctccatcg agaaaaccat ctccaaagcc aaagggcagc cccgagagcc acaggtgtac 780
accctgcccc catcccagga ggagatgacc aagaaccagg tcagcctgac ctgcctggtc 840
aaaggcttct accccagcga catcgccgtg gagtgggaaa gcaatgggca gccggagaac 900
aactacaaga ccacgcctcc cgtgctggac tccgacggct ccttcttcct ctacagcagg 960
ctaaccgtgg acaagagcag gtggcaggag gggaatgtct tctcatgctc cgtgatgcat 1020
gaggctctgc acaaccacta cacacagaag agcctctccc tgtctctggg ttgataactc 1080
gag 1083
<210> 8
<211> 29
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> primer SeqPF
<400> 8
accggaattc tcagatccgc tagcgctac 29
<210> 9
<211> 33
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<220>
<223> primer SeqPR
<400> 9
tgagctcgag atcagagtcc ggacttgtac agc 33

Claims (3)

1. The application of a lentivirus recombinant expression vector in preparing a high-efficiency expression stable cell strain is characterized in that: the lentiviral recombinant expression vector comprises a lentiviral vector skeleton containing a Tet-off expression regulation system and a promoter A; the promoter A is arranged at the upstream of the tTA2 expression element and is used for directly driving the tTA2 to express;
the promoter A is a weak promoter, specifically an S100a6 promoter, a CIRP promoter or a PDI promoter;
the CIRP promoter is a CIRP-P867 promoter with a nucleotide sequence shown as SEQ ID NO.1 or a CIRP-P2588 promoter with a nucleotide sequence shown as SEQ ID NO. 2;
the PDI promoter is a PDI-P598 promoter with a nucleotide sequence shown as SEQ ID NO. 3;
the S100a6 promoter is an S100a6-dS18 promoter with a nucleotide sequence shown in SEQ ID NO. 4;
the slow virus vector skeleton is pLUT-off;
the nucleotide sequence of the pLUT-off is shown as SEQ ID NO. 5;
the cells are CHO cells.
2. A method for constructing a high-efficiency expression stable cell strain by using a lentivirus infection method is characterized by comprising the following steps:
(1) Cloning a target protein gene into a multiple cloning site in the lentiviral recombinant expression vector of claim 1 to obtain a lentiviral vector capable of expressing the target protein;
(2) Carrying out slow virus packaging on slow virus vectors capable of expressing target proteins to obtain virus liquid;
(3) Infecting host cells with the obtained virus liquid to obtain a high-efficiency expression stable cell bank; monoclonal screening is carried out on the cell bank to obtain a high-efficiency expression stable cell strain;
the target protein gene in the step (1) comprises RFP, GFP, EGFP, luciferase and GLP-1-Fc;
the nucleotide sequence of the GLP-1-Fc recombinant protein is shown as SEQ ID NO. 7.
3. The method for constructing a stable cell line with high expression by using lentiviral infection method according to claim 2, wherein:
the specific steps of lentiviral packaging described in step (2) are as follows: mixing the lentiviral vector in the step (1) with a packaging plasmid to obtain a packaging system; transfecting the packaging system into HEK 293T cells for culture; then changing fresh culture medium, continuously culturing to obtain virus liquid;
the host cell described in step (3) is a CHO cell;
the step (3) is specifically as follows: taking lentivirus suspension obtained through centrifugation and filtration treatment, and infecting host cells; after the virus liquid infects cells for 4 to 6 hours, fresh CD culture medium is added for continuous culture; changing fresh culture medium 46-48 hours after virus liquid infects cells; 4-5 days after virus liquid infects cells, detecting protein expression intensity to obtain a high-efficiency stable expression cell bank; and (3) carrying out monoclonal screening on the cell library to obtain the high-efficiency expression stable cell strain.
CN202010004714.5A 2020-01-03 2020-01-03 Application of Tet-off expression control system in cascade amplification of promoter activity Active CN113073118B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010004714.5A CN113073118B (en) 2020-01-03 2020-01-03 Application of Tet-off expression control system in cascade amplification of promoter activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010004714.5A CN113073118B (en) 2020-01-03 2020-01-03 Application of Tet-off expression control system in cascade amplification of promoter activity

Publications (2)

Publication Number Publication Date
CN113073118A CN113073118A (en) 2021-07-06
CN113073118B true CN113073118B (en) 2023-09-15

Family

ID=76608398

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010004714.5A Active CN113073118B (en) 2020-01-03 2020-01-03 Application of Tet-off expression control system in cascade amplification of promoter activity

Country Status (1)

Country Link
CN (1) CN113073118B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105331635A (en) * 2015-11-05 2016-02-17 深圳大学 Induced slow virus expression system and construction method and application thereof
CN107523588A (en) * 2017-08-18 2017-12-29 深圳大学 A kind of tetracycline slow virus inducible expression carrier and its method for building up and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3412775A4 (en) * 2016-02-05 2019-07-31 Slbigen Inc. Mesenchymal stem cell expressing trail and cd, and use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105331635A (en) * 2015-11-05 2016-02-17 深圳大学 Induced slow virus expression system and construction method and application thereof
CN107523588A (en) * 2017-08-18 2017-12-29 深圳大学 A kind of tetracycline slow virus inducible expression carrier and its method for building up and application

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
CHO细胞表达系统启动子;王稳等;《中国生物化学与分子生物学报》;20191120;第35卷(第11期);摘要,第1178页"4 内源性启动子"和"5 诱导型启动子" *
Constitutive Gs activation using a single-construct tetracycline-inducible expression system in embryonic stem cells and mice;Edward C Hsiao等;《Stem Cell Research & Therapy》;20110304(第02期);第1-12页 *
Engineered and Natural Promoters and Chromatin-Modifying Elements for Recombinant Protein Expression in CHO Cells;Nadiya Romanova等;《Biotechnology Journal》;20171116;第13卷(第03期);第1-13页 *
High-level transgene expression in neurons by lentivirus with Tet-Off system;Hiroyuki Hioki等;《Neuroscience Research》;20090228;第63卷(第02期);摘要和第149页"2 材料与方法",第151页"3 结果与讨论",图1-2 *
Hiroyuki Hioki等.High-level transgene expression in neurons by lentivirus with Tet-Off system.《Neuroscience Research》.2009,第63卷(第02期), *
Tet-on系统诱导猿猴病毒40T在CHO细胞中的表达;朱洪等;《扬州大学学报(农业与生命科学版)》;20050930(第03期);第12-16页 *
Tetracycline-controlled genetic switches;R. Sprengel等;《Conditional Mutagenesis: An Approach to Disease Models》;20071231(第178期);第65页第3段,第66页第1段,图6 *
一种新型的Tet-off慢病毒调控系统的构建及其调控作用;杨春燕等;《浙江理工大学学报》;20100910;第27卷(第05期);摘要,第806页"1 材料与方法",第808页"3 讨论" *
可诱导慢病毒载体的优化策略及应用;黄芳等;《细胞生物学杂志》;20071215(第06期);第809-815页 *
四环素类抗生素对基因表达的影响及其应用;李红霞等;《药学进展》;20040930(第09期);第391-395页 *
慢病毒载体的设计及应用进展;王淑艳等;《中国生物工程杂志》;20061125(第11期);第70-75页 *
时空表达可控的转基因动物模型调控体系的研究;孙敬方;《中国实验动物学报》;20050630(第02期);第72-75页 *
杜娟等.诱导表达载体系统.《医学细胞与分子生物学理论与技术》.吉林大学出版社,2012, *
赵爱春等.四环素诱导表达技术.《家蚕转基因技术及应用》.上海科学技术出版社,2017, *

Also Published As

Publication number Publication date
CN113073118A (en) 2021-07-06

Similar Documents

Publication Publication Date Title
AU695811B2 (en) Hybrid adenovirus-AAV virus and methods of use thereof
US6251677B1 (en) Hybrid adenovirus-AAV virus and methods of use thereof
KR102516695B1 (en) Incorporation of unnatural amino acids into proteins
KR102648489B1 (en) Chemically modified guide RNA for CRISPR/CAS-mediated gene regulation
CN114836444B (en) Recombinant enterovirus A71 virus-like particle and application thereof
CN106687590B (en) Yellow fever virus-like particles
US20030162265A1 (en) Dna joining method
CN115397983A (en) Targeted transfer RNA for treatment of disease
JP2024037917A (en) Techniques for generating cell-based therapeutics using recombinant t cell receptor genes
CN103834692A (en) Lentiviral vector for expressing lncRNA (long noncoding ribonucleic acid) and application thereof
KR102084227B1 (en) Human transformed chondrocyte cell line mediated drug screening system for cartilage disease remedy
IE64613B1 (en) Carrier-bound recombinant proteins processes for their production and use as immunogens and vaccines
CN110582305A (en) Vectors and compositions for the treatment of hemoglobinopathies
KR102385078B1 (en) Pharmaceutical composition for the prevention and treatment of Envelopled viruses comprising taining Platycodon grandiflorus root extracts
CN113073118B (en) Application of Tet-off expression control system in cascade amplification of promoter activity
KR20230019156A (en) Cell lines with multiple docks for gene insertion
KR20240095087A (en) Lentiviral vectors useful for the treatment of diseases
CN110312803B (en) Compositions and methods for editing nucleic acid sequences
CN110514628A (en) A kind of biological inductor/the method and application of quick detection O-GlcNAc modification
CN114107395B (en) Method for constructing feeder layer cells for high expression of pig PBMCs cytokines
RU2823437C2 (en) Treatment and/or prevention of disease or syndrome associated with viral infection
CA2402321C (en) Dna joining method
KR20230005965A (en) Treatment and/or prevention of diseases or syndromes associated with viral infections
CN111849985A (en) Method for replacing endogenous gene segments in non-homologous end connection mode
CN111411109A (en) Gene expression element of fungal operon and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant